The Management of Cerebral Palsy: Subjectivity and a Conundrum

Abstract

Get full access to this article

View all access options for this article.

References

Young RR , Delwaide PJ : Drug therapy: Spasticity. N Engl J Med 1981 ;304:28-33.

Albright AL : Baclofen in the treatment of cerebral palsy. J Child Neurol 1996;11:77-83.

Landau WM , Hunt CC : Dorsal rhizotomy, a treatment of unproven efficacy. J Child Neurol 1990;5:174-177.

Kaufman HH , Bodensteiner JB , Burkhart B. , et al: Treatment of spastic gait in cerebral palsy. W Va Med J 1994;90:190-192.

Chutorian AM , Root L. : Management of spasticity in children with botulinum-A-toxin. Int Pediatr 1994;9(Suppl 1):35-43.

Steinbok P. , Daneshvar H. , Evans D. , Kestle Jrw : Cost analysis of continuous intrathecal baclofen versus selective functional posterior rhizotomy in the treatment of spastic quadriplegia associated with cerebral palsy. Pediatr Neurosurg 1995 ;22:255-265.

Peacock WJ , Staudt LA : Spasticity in cerebral palsy and the selective posterior rhizotomy procedure . J Child Neurol 1990; 5:179-185.

Bodensteiner JB , Kaufman HH , Burkhart B. , et al: Correlation of change in spasticity and functional outcome after selective dorsal root section for spasticity . Neurology 1994;44(Suppl 2):A312.